Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001576885-25-000033
Filing Date
2025-01-23
Accepted
2025-01-23 17:16:46
Documents
1
Period of Report
2025-01-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1737670600.html 4  
1 FORM 4 wk-form4_1737670600.xml 4 3476
  Complete submission text file 0001576885-25-000033.txt   4942
Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Issuer) CIK: 0001576885 (see all company filings)

EIN.: 364108129 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O GENOCEA BIOSCIENCES, INC. 100 ACORN PARK DRIVE, 5TH FLOOR CAMBRIDGE MA 02140
Business Address
Meisner Derek M (Reporting) CIK: 0001752461 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40551 | Film No.: 25550992